The abuse and misuse of OTC medicines is a common problem in community pharmacies and is expected to escalate during the COVID-19 pandemic. However, there is limited research on the patterns, causes, and consequences of these incidents during the pandemic. This article aims to provide evidence-based insights into the potential impact of COVID-19 on the abuse and misuse of OTC medicines, and suggest strategies for reducing these occurrences for pharmacy practitioners and healthcare managers.
CooperRJ.Over-the-counter medicine abuse - a review of the literature. J Subst Use. 2013;18(2):82-107. doi:10.3109/14659891.2011.615002
2.
HughesGFMcElnayJCHughesCMMcKennaP.Abuse/misuse of non-prescription drugs. Pharm World Sci. 1999;21(6):251-255.
3.
Quincho-LopezABenites-IbarraCAHilario-GomezMMQuijano-EscateRTaype-RondanA.Self-medication practices to prevent or manage COVID-19: a systematic review. PLoS One. 2021;16(11):e0259317. doi:10.1371/journal.pone.0259317
4.
KarlssonPNakitandaAOLöflingLCestaCE.Patterns of prescription dispensation and over-the-counter medication sales in Sweden during the COVID-19 pandemic. PLoS One. 2021;16(8):e0253944. doi:10.1371/journal.pone.0253944
5.
UnniEJPatelKBeazerIRHungM.Telepharmacy during COVID-19: a scoping review. Pharmacy. 2021;9(4):183. doi:10.3390/pharmacy9040183
6.
SchersHvan WeelCvan BovenKAkkermansRBischoffEolde HartmanT.The COVID-19 pandemic in Nijmegen, the Netherlands: changes in presented health problems and demand for primary care. Ann Fam Med. 2021;19(1):44-47. doi:10.1370/afm.2625
StasioMJCurryKSutton-SkinnerKMGlassmanDM.Over-the-Counter medication and herbal or dietary supplement use in college: dose frequency and relationship to self-reported distress. J Am Coll Health. 2008;56(5):535-547. doi:10.3200/JACH.56.5.535-548
9.
SchwabRStewenKKottmannT, et al. Factors associated with increased analgesic use in German women with endometriosis during the COVID-19 pandemic. J Clin Med. 2022;11:19. doi:10.3390/jcm11195520
10.
ZaamiSMarinelliEVarìMR.New trends of substance abuse during COVID-19 pandemic: an international perspective. Front Psychiatry. 2020;11:700. doi:10.3389/fpsyt.2020.00700
AyosanmiOSAlliBYAkingbuleOA, et al. Prevalence and correlates of self-medication practices for prevention and treatment of COVID-19: a systematic review. Antibiotics. 2022;11(6):808. doi:10.3390/antibiotics11060808
13.
RayIBardhanMHasanMM, et al. Over the counter drugs and self-medication: A worldwide paranoia and a troublesome situation in India during the COVID-19 pandemic. Ann Med Surg. 2022;78:103797. doi:10.1016/j.amsu.2022.103797
14.
ShresthaABAryalMMagarJRShresthaSHossainyLRimtiFH.The scenario of self-medication practices during the covid-19 pandemic; a systematic review. Ann Med Surg. 2022;82:104482. doi:10.1016/j.amsu.2022.104482
15.
YáñezJAChungSARománBR, et al. Prescription, over-the-counter (OTC), herbal, and other treatments and preventive uses for COVID-19. Environ Heal Manag Nov Coronavirus Dis (COVID-19). 2021:379-416. doi:10.1016/B978-0-323-85780-2.00001-9
16.
GabarronEOyeyemiSOWynnR.COVID-19-related misinformation on social media: a systematic review. Bull World Health Organ. 2021;99(6):455-463A. doi:10.2471/BLT.20.276782
17.
RuizME.Risks of self-medication practices. Curr Drug Saf. 2010;5(4):315-323. doi:10.2174/157488610792245966
18.
GohLYVitryAISempleSJEstermanALuszczMA.Self-medication with over-the-counter drugs and complementary medications in South Australia’s elderly population. BMC Complement Altern Med. 2009;9(1):42. doi:10.1186/1472-6882-9-42
19.
AlKhafajiDAl ArganRAlbakerW, et al. The impact of vitamin D level on the severity and outcome of hospitalized patients with COVID-19 disease. Int J Gen Med. 2022;15:343-352. doi:10.2147/IJGM.S346169
DettmannLMAdamsSTaylorG.Investigating the prevalence of anxiety and depression during the first COVID-19 lockdown in the United Kingdom: Systematic review and meta-analyses. Br J Clin Psychol. 2022;61(3):757-780. doi:10.1111/bjc.12360
22.
SmithJPBookSW.Anxiety and Substance Use Disorders: A Review. Psychiatric Times. 2008;25(10):19-23.
FinleyEPGarciaARosenKMcGearyDPughMJPotterJS.Evaluating the impact of prescription drug monitoring program implementation: a scoping review. BMC Health Serv Res. 2017;17(1):420. doi:10.1186/s12913-017-2354-5
25.
CumminsMTurcotteCMcFarlandMMStaesC.Research outcomes of linked prescription drug monitoring program data: a scoping review protocol. BMJ Open. 2022;12(4):e055290. doi:10.1136/bmjopen-2021-055290
26.
DizonDSGrahamDThompsonMA, et al. Practical guidance: the use of social media in oncology practice. J Oncol Pract. 2012;8(5):e114-e124. doi:10.1200/JOP.2012.000610
27.
AntiportaDABruniA.Emerging mental health challenges, strategies, and opportunities in the context of the COVID-19 pandemic: Perspectives from South American decision-makers. Rev Panam Salud Publica. 2020;44:e154. doi:10.26633/RPSP.2020.154
28.
Mohamed IbrahimOIbrahimRMIbrahimYAMadawiEAAl DeriMY.Shedding the light on pharmacists’ roles during COVID-19 global pandemic. Saudi Pharm J. 2022;30(1):14-27. doi:10.1016/j.jsps.2021.12.003
29.
GiulianiMPapadakosTPapadakosJ.Propelling a new era of patient education into practice-cancer care post-COVID-19. Int J Radiat Oncol Biol Phys. 2020;108(2):404-406. doi:10.1016/j.ijrobp.2020.05.036
